Overview: Group A Streptococcus Antigen TestIntroduction: The Group A Streptococcus Antigen Test detects Group A Streptococcus, causing strep throat or skin infections, helping guide antibiotic treatment for sore throat or fever. Affecting 1 in 10,000 people annually with strep throat, this infection poses diagnostic challenges due to rapid spread. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses rapid antigen testing for high speed, supporting bacteriology screening. This test is vital for diagnosis, treatment planning, and improving outcomes in infectious disease.
Other Names: Strep A Rapid Test, Group A Strep Assay.
FDA Status: FDA-cleared rapid test, CLIA-waived, meeting bacteriology standards for diagnostic reliability.
Historical Milestone: Streptococcal testing began in the 1930s with research by Lancefield, who classified Group A Streptococcus. Rapid antigen advancements in the 1980s by Abbott improved detection, surpassing earlier culture methods.
Purpose: Detects Group A Streptococcus to diagnose strep throat or skin infections, guides antibiotic therapy, and evaluates patients with sore throat, aiming to prevent complications.
Test Parameters: Group A Streptococcus presence
Pretest Condition: Fresh throat swab required. Collect swab. Report history of throat or skin symptoms.
Specimen: Throat Swab, Nasal Swab (sterile swab/transport medium, 1-2 swabs); Throat swab in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document sore throat or fever. Include current medications or recent antibiotic use.
Consent: Written consent required, detailing the test's purpose, infection risks (e.g., rheumatic fever), and sample collection risks.
Procedural Considerations: Uses rapid antigen test to detect Streptococcus, requiring labs with test kits. Results available in 1 day. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample contamination or delay can affect results. Antibiotics may reduce detection, requiring correlation.
Clinical Significance: Positive result confirms infection, guiding therapy. Early treatment might prevent complications, while untreated cases lead to rheumatic fever. Negative results may require culture.
Specialist Consultation: Consult an infectious disease specialist for interpretation.
Additional Supporting Tests: Throat culture, anti-streptolysin O titer, or PCR to confirm diagnosis.
Test Limitations: Specific to Group A Streptococcus; correlation with symptoms needed. False negatives possible with low bacterial load.
References: CDC Guidelines, 2023; Journal of Clinical Microbiology, Lancefield RC, 2022.
